Generated: April 30, 2017
|Title:||Medicament to combat autoimmune diseases|
|Abstract:||A pharmaceutical composition for use in the treatment of chronic Graft-versus-host diseases as well as autoimmune diseases, in particular for the treatment of systemic lupus erythematosus containing as an active ingredient at least one compound of the formulae 1 or 2 ##STR1## the latter being present per se or in the form of a physiologically tolerable salt. The invention also relates to a dosage unit form of said pharmaceutical composition and a method of treating chronic Graft-versus host diseases as well as autoimmune diseases, in particular systemic lupus erythematosus.|
|Inventor(s):||Bartlett; Robert R. (Darmstadt, DE), Schleyerbach; Rudolph (Hofheim am Taunus, DE), Kammerer; Friedrich-Johannes (Hochheim am Main, DE)|
|Assignee:||Hoechst Aktiengesellschaft (Frankfurt, DE)|
|Patent Claims:||1. A composition comprising N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide having the formula: ##STR2## and a pharmaceutically acceptable carrier.|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.